REMINDER: Our user survey closes on Friday, please submit your responses here.
Agree that more info could well have given a different perspective but they rarely think of it... would be good to understand for sure.
What is substantial? There was £2.3m at Dec and then £2.7m Jan that’s a a £400k difference hardly emergency keeping the lights on.... and as stated elsewhere the revenue is severely H2 weighted and more than likely the latter part of H2 so revenue is building for sure and at a good rate. Patience is needed to invest, greed to trade...
Thanks for that info too Dafad, appreciated.
Cheers Rooky and not offended at all, just invested in BRH today and this led me here, my first thought was two way but then looked a little deeper at the certification stuff. Anyway, whatever, both RMS and BRH had stellar days today, that's all that counts. Best DB8er.
Check the ISO website as I see that when looking at EN14683 this certificate refers to one-way(although limited protection to the wearer): excerpt below, hence my thought.
Surgical masks to EN 14683:2019+AC:2019
Surgical face masks are intended to limit the transmission of infective agents.
Surgical face masks can also incorporate a microbial barrier that is designed to be effective in reducing the emission
of infective agents from the nose and mouth of a carrier or a patient with clinical symptoms. Surgical masks are
intended to be a barrier to infection of others though they do offer limited protection to the wearer.
On the Pharm to Farm website they state that they are Type IIR masks, which I believe and hands up if wrong, are just one-way protection.
Don't forget these masks stop the wearer spreading their germs, they do not protect you from inhaling them. They are designed for surgical use to stop the spread of germs by the wearer, if you want to protect yourself as well you need to have an N95 type mask, which is two way.
Let’s just wait and see Calamari, we have progress, not at the rate you want and we all see that, but I’m happy and this is a massive market. No matter our differing opinions or what we post, this will go where it goes and I have my opinion on that.
The £300k was over ten times the previous year and this was to June. Bids have also stated that they expect 2020 revenue to be significantly weighted to H2 so w3 should see greater than £300k for H2....how much? Personally at this price I’m not fussed, they’ve started, proved the model and we are off imo.
RNS was confirmation of previously shared news, the prize is still very much ahead.....and we are closer to it!
A very positive signal to start the day. Agree, TR-1 notification will be an interesting read and I think the next phase is just about to start imo.
Great start to the week, we’ve stayed pretty much under the radar so when the wider herd start to notice, the rest will take care of itself.
Don’t disagree that the Director purchase was a positive thing just stating fact. These guys are absolutely loaded, that was all. If I make my target today that’s great and I will be out and there will be a few shares on sale later courtesy of me for those that want to continue on the ride. That’s how it works yep? Let’s all have a good day.